Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
Submitted by
admin
on July 28, 2015 - 10:04am
Source:
Yahoo/Reuters
News Tags:
Hikma
Boehringer Ingelheim
generics
M&A
Headline:
Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
Do Not Allow Advertisers to Use My Personal information
